Table of Contents

• Robert J. McCarter,
• James M. Hempe,
• Ricardo Gomez,
• and Stuart A. Chalew

Biological Variation in HbA_1c Predicts Risk of Retinopathy and Nephropathy in Type 1 Diabetes

• Julio Rosenstock,
• David R. Hassman,
• Robert D. Madder,
• Shari A. Brazinsky,
• James Farrell,
• Naum Khutoryansky,
• and Paula M. Hale

Repaglinide Versus Nateglinide Monotherapy: A randomized, multicenter study

• Eiko Sato,
• Yoshimi Suzukamo,
• Mitsunori Miyashita,
• and Keiko Kazuma

Development of a Diabetes Diet-Related Quality-of-Life Scale

• Mieko Saito,
• Masaaki Eto,
• Hayami Nitta,
• Yukiko Kanda,
• Makoto Shigeto,
• Katsura Nakayama,
• Kazuhito Tawaramoto,
• Fumiko Kawasaki,
• Shinji Kamei,
• Kenji Kohara,
• Masafumi Matsuda,
• Michihiro Matsuki,
• and Kohei Kaku

Effect of Apolipoprotein E4 Allele on Plasma LDL Cholesterol Response to Diet Therapy in Type 2 Diabetic Patients

• Thomas M.S. Wolever,
• Janice E. Campbell,
• Daniela Geleva,
• and G. Harvey Anderson

High-Fiber Cereal Reduces Postprandial Insulin Responses in Hyperinsulinemic but not Normoinsulinemic Subjects

• Helaine E. Resnick,
• Elizabeth A. Carter,
• Robert Lindsay,
• Susan J. Henly,
• Frederick K. Ness,
• Thomas K. Welty,
• Elisa T. Lee,
• and Barbara V. Howard

Relation of Lower-Extremity Amputation to All-Cause and Cardiovascular Disease Mortality in American Indians: The Strong Heart Study

• Franco Cerutti,
• Graziella Bruno,
• Francesco Chiarelli,
• Renata Lorini,
• Franco Meschi,
• and Carla Sacchetti

Younger Age at Onset and Sex Predict Celiac Disease in Children and Adolescents With Type 1 Diabetes: An Italian multicenter study

• Gil F. Salles,
• Katia V. Bloch,
• and Claudia R.L. Cardoso

Mortality and Predictors of Mortality in a Cohort of Brazilian Type 2 Diabetic Patients

• Sheri L. Maddigan,
• Sumit R. Majumdar,
• Lisa M. Guirguis,
• Richard Z. Lewanczuk,
• T. K. Lee,
• Ellen L. Toth,
• and Jeffrey A. Johnson

Improvements in Patient-Reported Outcomes Associated With an Intervention to Enhance Quality of Care for Rural Patients With Type 2 Diabetes: Results of a controlled trial

• Marit Graue,
• Tore Wentzel-Larsen,
• Edvin Bru,
• Berit Rokne Hanestad,
• and Oddmund Søvik

The Coping Styles of Adolescents With Type 1 Diabetes Are Associated With Degree of Metabolic Control

• Julio Rosenstock,
• Joseph C. Cappelleri,
• Björn Bolinder,
• and Robert A. Gerber

Patient Satisfaction and Glycemic Control After 1 Year With Inhaled Insulin (Exubera) in Patients With Type 1 or Type 2 Diabetes

• Mohammed F. Saad,
• Susan Greco,
• Kwame Osei,
• Andrew J. Lewin,
• Christopher Edwards,
• Margarita Nunez,
• and Rickey R. Reinhardt

Ragaglitazar Improves Glycemic Control and Lipid Profile in Type 2 Diabetic Subjects: A 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm

• Dean T. Eurich,
• Sumit R. Majumdar,
• Ross T. Tsuyuki,
• and Jeffrey A. Johnson

Reduced Mortality Associated With the Use of ACE Inhibitors in Patients With Type 2 Diabetes

• Sten Madsbad,
• Ole Schmitz,
• Jonas Ranstam,
• Grethe Jakobsen,
• and David R. Matthews

Improved Glycemic Control With No Weight Increase in Patients With Type 2 Diabetes After Once-Daily Treatment With the Long-Acting Glucagon-Like Peptide 1 Analog Liraglutide (NN2211): A 12-week, double-blind, randomized, controlled trial

• Singhan T.M. Krishnan,
• Neil R. Baker,
• Anne L. Carrington,
• and Gerry Rayman

Comparative Roles of Microvascular and Nerve Function in Foot Ulceration in Type 2 Diabetes

• Andrea Natali,
• Stephanie Baldeweg,
• Elena Toschi,
• Brunella Capaldo,
• Daniele Barbaro,
• Amalia Gastaldelli,
• John S. Yudkin,
• and Ele Ferrannini

Vascular Effects of Improving Metabolic Control With Metformin or Rosiglitazone in Type 2 Diabetes

• Geesje M. Dallinga-Thie,
• Ingrid I.L. Berk-Planken,
• Aart H. Bootsma,
• and Hans Jansen

Atorvastatin Decreases Apolipoprotein C-III in Apolipoprotein B-Containing Lipoprotein and HDL in Type 2 Diabetes: A potential mechanism to lower plasma triglycerides

• Soren Snitker,
• Richard M. Watanabe,
• Ifeanyi Ani,
• Anny H. Xiang,
• Aura Marroquin,
• Cesar Ochoa,
• Jose Goico,
• Alan R. Shuldiner,
• and Thomas A. Buchanan

Changes in Insulin Sensitivity in Response to Troglitazone Do Not Differ Between Subjects With and Without the Common, Functional Pro12Ala Peroxisome Proliferator–Activated Receptor-γ2 Gene Variant: Results from the Troglitazone in Prevention of Diabetes (TRIPOD) study

• Angelo Avogaro,
• Richard M. Watanabe,
• Alessandra Dall’Arche,
• Saula Vigili De Kreutzenberg,
• Antonio Tiengo,
• and Giovanni Pacini

Acute Alcohol Consumption Improves Insulin Action Without Affecting Insulin Secretion in Type 2 Diabetic Subjects

• Alka M. Kanaya,
• Tamara Harris,
• Bret H. Goodpaster,
• Fran Tylavsky,
• and Steven R. Cummings

Adipocytokines Attenuate the Association Between Visceral Adiposity and Diabetes in Older Adults

• Yoshimasa Aso,
• Ki-ichi Okumura,
• Teruo Inoue,
• Rika Matsutomo,
• Noboru Yoshida,
• Sadao Wakabayashi,
• Kohzo Takebayashi,
• and Toshihiko Inukai

Results of Blood Inflammatory Markers Are Associated More Strongly With Toe-Brachial Index Than With Ankle-Brachial Index in Patients With Type 2 Diabetes

• Christophe E.M. De Block,
• Gert Colpin,
• Kristof Thielemans,
• Willy Coopmans,
• Johannes J.P.M. Bogers,
• Paul A. Pelckmans,
• Eric A.E. Van Marck,
• Viviane Van Hoof,
• Manou Martin,
• Ivo H. De Leeuw,
• Roger Bouillon,
• and Luc F. Van Gaal

Neuroendocrine Tumor Markers and Enterochromaffin-Like Cell Hyper/Dysplasia in Type 1 Diabetes

• Giorgio Sesti,
• Maria Alelaide Marini,
• Marina Cardellini,
• Angela Sciacqua,
• Simona Frontoni,
• Francesco Andreozzi,
• Concetta Irace,
• Davide Lauro,
• Agostino Gnasso,
• Massimo Federici,
• Francesco Perticone,
• and Renato Lauro

The Arg⁹⁷² Variant in Insulin Receptor Substrate-1 Is Associated With an Increased Risk of Secondary Failure to Sulfonylurea in Patients With Type 2 Diabetes

• Jennifer M. Barker,
• Stephanie H. Goehrig,
• Katherine Barriga,
• Michelle Hoffman,
• Robert Slover,
• George S. Eisenbarth,
• Jill M. Norris,
• Georgeanna J. Klingensmith,
• and Marian Rewers

Clinical Characteristics of Children Diagnosed With Type 1 Diabetes Through Intensive Screening and Follow-Up

• Kelley Martin,
• Penny Wallace,
• Philip F. Rust,
• and W. Timothy Garvey

Estimation of Resting Energy Expenditure Considering Effects of Race and Diabetes Status

• Hassan A. Kobaissi,
• Marc J. Weigensberg,
• Geoff D.C. Ball,
• Martha L. Cruz,
• Gabriel Q. Shaibi,
• and Michael I. Goran

Relation Between Acanthosis Nigricans and Insulin Sensitivity in Overweight Hispanic Children at Risk for Type 2 Diabetes

• James B. Meigs,
• Ken Williams,
• Lisa M. Sullivan,
• Kelly J. Hunt,
• Steven M. Haffner,
• Michael P. Stern,
• Clicerio González Villalpando,
• Jessica S. Perhanidis,
• David M. Nathan,
• Ralph B. D’Agostino, Jr,
• Ralph B. D’Agostino, Sr,
• and Peter W.F. Wilson

Using Metabolic Syndrome Traits for Efficient Detection of Impaired Glucose Tolerance

• Noriyuki Nakanishi,
• Kenji Suzuki,
• and Kozo Tatara

Serum γ-Glutamyltransferase and Risk of Metabolic Syndrome and Type 2 Diabetes in Middle-Aged Japanese Men

• Björn Zethelius,
• C. Nicholas Hales,
• Hans O. Lithell,
• and Christian Berne

Insulin Resistance, Impaired Early Insulin Response, and Insulin Propeptides as Predictors of the Development of Type 2 Diabetes: A population-based, 7-year follow-up study in 70-year-old men

• Kwame Osei,
• Scott Rhinesmith,
• Trudy Gaillard,
• and Dara Schuster

Impaired Insulin Sensitivity, Insulin Secretion, and Glucose Effectiveness Predict Future Development of Impaired Glucose Tolerance and Type 2 Diabetes in Pre-Diabetic African Americans: Implications for primary diabetes prevention

• Roderick E. Warren,
• Kate V. Allen,
• Andrew J. Sommerfield,
• Ian J. Deary,
• and Brian M. Frier

Acute Hypoglycemia Impairs Nonverbal Intelligence: Importance of avoiding ceiling effects in cognitive function testing

• Keiko Arimoto,
• Hideyuki Sasaki,
• Kenichi Ogawa,
• Hiroshi Yamasaki,
• Kunihisa Okamoto,
• Hiroto Furuta,
• Tadashi Hanabusa,
• Masahiro Nishi,
• Taisei Nakao,
• and Kishio Nanjo

Negative Pressure Suction During Blood Sampling May Reduce the Difference in Self-Monitoring of Blood Glucose Results Between Fingertip Pricking and Forearm Pricking

• Miguel Cruz,
• Rebeca García-Macedo,
• Yolanda García-Valerio,
• Margarita Gutiérrez,
• Rafael Medina-Navarro,
• Genoveva Duran,
• Niels Wacher,
• and Jesús Kumate

Low Adiponectin Levels Predict Type 2 Diabetes in Mexican Children

Polyunsaturated Fatty Acid Consumption May Play a Role in the Onset and Regression of Microalbuminuria in Well-Controlled Type 1 and Type 2 Diabetic People: A 7-year, prospective, population-based, observational multicenter study

• Andrew J.M. Boulton,
• Rayaz A. Malik,
• Joseph C. Arezzo,
• and Jay M. Sosenko

Diabetic Somatic Neuropathies

• Tara M. Wallace,
• Jonathan C. Levy,
• and David R. Matthews

Use and Abuse of HOMA Modeling

• Ronald M. Krauss

Lipids and Lipoproteins in Patients With Type 2 Diabetes

• Rajiv Goonetilleke,
• Melanie Pollitzer,
• and Nick Mann

Insulin for Toddlers With Difficult Diabetes

• Zachary T. Bloomgarden

Diabetes Complications

• Tanya M. Osicka,
• Richard J. MacIsaac,
• George Jerums,
• and Wayne D. Comper

High Prevalence of Immunounreactive Albumin in Urine From Diabetic Patients With a Low Glomerular Filtration Rate and Normoalbuminuria

• Elia B. Marquez,
• Benjamin R. Diaz,
• and Patrick L. Gurian

Understanding the Associations Between Statewide Diabetes Prevalence and Air Pollution Emissions

• Leilani Greening,
• Laura Stoppelbein,
• George Moll,
• Nicole Palardy,
• and Matthew Hocking

Intrinsic Motivation and Glycemic Control in Adolescents with Type 1 Diabetes

• Rebecca L. Pollex,
• Hafiz M.R. Khan,
• Philip W. Connelly,
• T. Kue Young,
• and Robert A. Hegele

The Metabolic Syndrome in Inuit

• Kent Doi,
• Eisei Noiri,
• and Katsushi Tokunaga

The Association of NAD(P)H Oxidase p22phox With Diabetic Nephropathy Is Still Uncertain: Response to Hodgkinson, Millward, and Demaine

• Andrea D. Hodgkinson,
• Beverley A. Millward,
• and Andrew G. Demaine

The Association of NAD(P)H Oxidase p22phox With Diabetic Nephropathy Is Still Uncertain: Response to Doi, Noiri, and Tokunaga

• Norbert Stefan,
• Michael Stumvoll,
• Hans-Ulrich Häring,
• and Andreas Fritsche

Adiponectin in Youth: Response to Bacha et al.

• Fida Bacha,
• Rola Saad,
• Neslihan Gungor,
• and Silva A. Arslanian

Adiponectin in Youth: Response to Stefan et al.

• Thomas Kaiser,
• Christiane Florack,
• and Peter T. Sawicki

Kidney Function During and After Withdrawal of Long-Term Irbesartan Treatment in Patients With Type 2 Diabetes and Microalbuminuria: Response to Andersen, Bröchner-Mortensen, and Parving

• Steen Andersen,
• Jens Bröchner-Mortensen,
• and Hans-Henrik Parving

Kidney Function During and After Withdrawal of Long-Term Irbesartan Treatment in Patients With Type 2 Diabetes and Microalbuminuria: Response to Kaiser, Florack, and Sawicki

Erratum